Generate Biomedicines, Inc. (GENB) Stock Research

Thursday

Generate Biomedicines reports Q2 EPS (52c), consensus (49c)

GENB

Aug 6, 8:01 AM

Over a week ago

Generate Biomedicines falls -9.5%

GENB

Jul 10, 12:00 PM

Generate Biomedicines price target raised by $2 at Morgan Stanley

GENB

May 14, 8:11 AM

Generate Biomedicines price target raised by $9 at H.C. Wainwright, here's why

GENB

May 8, 6:28 AM

Generate Biomedicines reports Q1 revenue $7.22M, consensus $4.75M

GENB

May 7, 6:28 AM

Generate Biomedicines initiated with bullish view at H.C. Wainwright, here's why

GENB

Apr 13, 6:11 AM

Generate Biomedicines initiated with bullish view at Cantor Fitzgerald, here's why

GENB

Mar 24, 7:50 AM

Generate Biomedicines initiated with bullish view at Cantor Fitzgerald

GENB

Mar 24, 6:23 AM

Generate Biomedicines initiated with bullish view at Guggenheim, here's why

GENB

Mar 24, 5:12 AM

Generate Biomedicines initiated with bullish view at Morgan Stanley, here's why

GENB

Mar 24, 5:09 AM

Generate Biomedicines initiated with bullish view at Piper Sandler, here's why

GENB

Mar 24, 4:58 AM

Generate Biomedicines initiated with bullish view at Goldman Sachs, here's why

GENB

Mar 24, 4:34 AM

Opening Day: Janus Living opens at $23.50 after upsized IPO

Mar 23, 11:28 AM

Opening Day: Generate Biomedicines makes public debut

+10

Mar 2, 11:26 AM

Generate Biomedicines opens at $15.00, IPO priced at $16.00

GENB

Feb 27, 12:52 PM

Generate Biomedicines 25M share IPO priced at $16.00

GENB

Feb 26, 8:00 PM

No more stories